Literature DB >> 6234468

Non-specific immunosuppression by Cryptococcus neoformans infection.

R Blackstock, N K Hall.   

Abstract

Cryptococcus neoformans-infected animals were found to be immunosuppressed when tested by a variety of assays for immune competence. Primary humoral immune responses and delayed-type hypersensitivity reactions to sheep erythrocytes were suppressed in animals which had been infected for two weeks. Lymphocyte proliferation (LP) assays to sRBC stroma were also significantly diminished at two weeks of infection. Spleen cells of infected mice suppressed the LP response of sRBC immunized, normal mice in vitro. At least a part of the suppression could be attributed to a nylon wool non-adherent cell. Suppressor cells continued to be present in spleen cell suspensions following treatment with anti-T cell serum or anti-immunoglobulin and complement. When infected spleen cells were separated by adherence to plastic, both the adherent and non-adherent fractions exhibited suppressive activity. Incubation of infected spleen cells in tissue culture for 48 hr resulted in the elaboration of soluble immunosuppressive factors into the tissue culture medium. These data indicated that immune suppression in cryptococcosis can occur as a result of infection with Cryptococcus neoformans, and that at least one mechanism involved is the induction of adherent and non-adherent suppressor cells in the spleens of infected mice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234468     DOI: 10.1007/bf00437227

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

1.  Distinction between suppressors of the delayed-type hypersensitivity and the humoral response to sheep erythrocytes.

Authors:  K Yamaguchi; S Kishimoto
Journal:  Immunology       Date:  1978-11       Impact factor: 7.397

2.  Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans.

Authors:  R D Diamond; J E Bennett
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

3.  Cell-mediated immunity in Cryptococcosis.

Authors:  J R Graybill; R H Alford
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

4.  Serology of human cryptococcosis.

Authors:  D D Bindschadler; J E Bennett
Journal:  Ann Intern Med       Date:  1968-07       Impact factor: 25.391

5.  Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen.

Authors:  J S Goodman; L Kaufman; M G Koenig
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

6.  Immunoregulatory responses in experimental disseminated histoplasmosis: depression of T-cell-dependent and T-effectory responses by activation of splenic suppressor cells.

Authors:  R P Artz; W E Bullock
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Generation of disparate immunoregulatory factors in two inbred strains of mice with disseminated histoplasmosis.

Authors:  G S Deepe; S R Watson; W E Bullock
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

8.  Immunoregulation in disseminated histoplasmosis: characterization of splenic suppressor cell populations.

Authors:  D A Nickerson; R A Havens; W E Bullock
Journal:  Cell Immunol       Date:  1981-05-15       Impact factor: 4.868

9.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

10.  Cellular recognition by mouse lymphocytes in vitro. I. Definition of a new technique and results of stimulation by phytohemagglutinin and specific antigens.

Authors:  W H Adler; T Takiguchi; B Marsh; R T Smith
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  11 in total

1.  Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis.

Authors:  R A Cox; W Kennell; L Boncyk; J W Murphy
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

2.  Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival.

Authors:  R Blackstock; A Casadevall
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

3.  Induction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologic tolerance.

Authors:  R Blackstock; J M McCormack; N K Hall
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

4.  Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice.

Authors:  C A Salkowski; E Balish
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  Immunoadjuvant effect of inactivated Cryptococcus neoformans.

Authors:  Z Hubálek
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

6.  Regulation of cytokine expression in mice immunized with cryptococcal polysaccharide, a glucuronoxylomannan (GXM), associated with peritoneal antigen-presenting cells (APC): requirements for GXM, APC activation, and interleukin-12.

Authors:  R Blackstock; N McElwee; E Neller; J Shaddix-White
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 7.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

8.  Cryptococcus neoformans induces antimicrobial responses and behaves as a facultative intracellular pathogen in the non mammalian model Galleria mellonella.

Authors:  Nuria Trevijano-Contador; Inés Herrero-Fernández; Irene García-Barbazán; Liliana Scorzoni; Cristina Rueda; Suélen Andreia Rossi; Rocío García-Rodas; Oscar Zaragoza
Journal:  Virulence       Date:  2015       Impact factor: 5.882

9.  T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 10.  What makes Cryptococcus neoformans a pathogen?

Authors:  K L Buchanan; J W Murphy
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.